Therapeutic evaluation of various modalities in keloid

Author:

Gamit Hemangini H.1ORCID,Karia Umesh K.2,Shah Bela J.

Affiliation:

1. BJ Medical Collage, Ahmedabad, Gujarat, India

2. B

Abstract

Keloid is deregulated fibroproliferative growth in response to tissue injury. Keloids are known for their stubborn nature and present as therapeutic challenges in practice. Aim of our study is to evaluate various treatment modalities for search of treatment which stand out with maximum efficacy and least side effect. 120 patients with presternal keloid (female and male, aged 18-60 years) were recruited to receive one of the five treatment methods which were(1) Cryotherapy,(2) Cryotherapy and intralesional Triamcinolone acetonide,(3) Cryotherapy and intralesional 5- Fluorouracil(4) Cryotherapy and combination of Intralesional Triamcinolone acetonide with 5- Fluorouracil(5) Cryotherapy and Intralesional Triamcinolone acetonide combined with Silicone gel sheet application in each group respectively. Evaluation done by the Patient and Observer Scar Assessment Scale (POSAS) score at every 3 week till 6 months. Patients with significant improvement (> 50% reduction in POSAS) were 42%, 75%, 75%, 85%, and 90% in each 5 group respectively. Side effects like Hypopigmentation and Skin atrophy were significantly much frequent in group 2 while skin ulceration and pain were common with group 3. Group 1 showed maximum recurrence of lesion while no recurrence was seen in group-2 and 5 even after 3 month of post treatment. Among nonsurgical treatment modalities, Cryotherapy along with intralesional medication like triamcinolone acetonide and 5 fluorouracil and adjuvant therapy like silicone gel sheet are promising, inexpensive and an effective OPD based treatment that provide good alternative for keloid treatment in comparison to surgical procedures.

Publisher

IP Innovative Publication Pvt Ltd

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3